{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T11:20:57Z","timestamp":1782472857585,"version":"3.54.5"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.bmc.2021.116531","type":"journal-article","created":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T12:56:07Z","timestamp":1638536167000},"page":"116531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV\u20111 non-nucleoside reverse transcriptase inhibitors"],"prefix":"10.1016","volume":"53","author":[{"given":"Shujing","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghua","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongwei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xujie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasulu","family":"Cherukupalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"De Clercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Pannecouque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2021.116531_b0005","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bcp.2012.12.011","article-title":"Antivirals: past, present and future","volume":"85","author":"De Clercq","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmc.2021.116531_b0010","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.apsb.2015.09.001","article-title":"An Odyssey in antiviral drug development-50 years at the Rega Institute: 1964-2014","volume":"5","author":"De Clercq","year":"2015","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.bmc.2021.116531_b0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.antiviral.2009.10.007","article-title":"Current status and challenges of antiretroviral research and therapy","volume":"85","author":"Est\u00e9","year":"2010","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmc.2021.116531_b0020","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ijantimicag.2019.02.007","article-title":"Prevalence of predicted resistance to doravirine in HIV-1-positive patients after exposure to non-nucleoside reverse transcriptase inhibitors","volume":"53","author":"Sterrantino","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bmc.2021.116531_b0025","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/jac\/dky464","article-title":"Rare occurrence of doravirine resistance-associated mutations in HIV-1-infected treatment-naive patients","volume":"74","author":"Soulie","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bmc.2021.116531_b0030","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1021\/jm040838n","article-title":"Synthesis of novel diarylpyrimidine analogues and their antiviral activity against human immunodeficiency virus type 1","volume":"48","author":"Guillemont","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116531_b0035","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2174\/092986711794839142","article-title":"Recent advances in DAPYs and related analogues as HIV-1 NNRTIs","volume":"18","author":"Chen","year":"2011","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmc.2021.116531_b0040","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.apsb.2019.09.007","article-title":"Improving the positional adaptability: structure-based design of biphenyl-substituted diaryltriazines as novel non-nucleoside HIV-1 reverse transcriptase inhibitors","volume":"10","author":"Jin","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.bmc.2021.116531_b0045","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2217\/17469600.2.6.525","article-title":"Etravirine: a second-generation NNRTI for treatment-experienced adults with resistant HIV-1 infection","volume":"2","author":"Minuto","year":"2008","journal-title":"Futur HIV Ther"},{"key":"10.1016\/j.bmc.2021.116531_b0050","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.apsb.2019.08.013","article-title":"Exploring the hydrophobic channel of NNIBP leads to the discovery of novel piperidine-substituted thiophene[3,2-d]pyrimidine derivatives as potent HIV-1 NNRTIs","volume":"10","author":"Kang","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.bmc.2021.116531_b0055","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1021\/acs.jmedchem.8b00843","article-title":"The journey of HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) from lab to clinic","volume":"62","author":"Namasivayam","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116531_b0060","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1021\/acs.jmedchem.5b00497","article-title":"Anti-HIV drug discovery and development: current innovations and future trends","volume":"59","author":"Zhan","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116531_b0065","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1021\/jm00061a022","article-title":"5-chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase","volume":"36","author":"Williams","year":"1993","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116531_b0070","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1021\/jm0211063","article-title":"Novel indolyl aryl sulfones active against HIV-1 carrying NNRTI resistance mutations: synthesis and SAR studies","volume":"46","author":"Silvestri","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116531_b0075","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.bmcl.2007.11.085","article-title":"Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)","volume":"18","author":"Zhao","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2021.116531_b0080","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1021\/jm801470b","article-title":"Indolylarylsulfones bearing natural and unnatural amino acids. Discovery of potent inhibitors of HIV-1 non-nucleoside wild type and resistant mutant strains reverse transcriptase and coxsackie B4 virus","volume":"52","author":"Piscitelli","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116531_b0085","doi-asserted-by":"crossref","first-page":"6634","DOI":"10.1021\/jm300477h","article-title":"New nitrogen containing substituents at the indole-2-carboxamide yield high potent and broad spectrum indolylarylsulfone HIV-1 non-nucleoside reverse transcriptase inhibitors","volume":"55","author":"La Regina","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116531_b0090","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejmech.2016.10.009","article-title":"Discovery of novel piperidine-substituted indolylarylsulfones as potent HIV NNRTIs via structure-guided scaffold morphing and fragment rearrangement","volume":"126","author":"Li","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2021.116531_b0095","doi-asserted-by":"crossref","DOI":"10.1177\/2040206617753443","article-title":"Indolylarylsulfones, a fascinating story of highly potent human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors","volume":"26","author":"Famiglini","year":"2018","journal-title":"Antivir Chem Chemother"},{"key":"10.1016\/j.bmc.2021.116531_b0100","doi-asserted-by":"crossref","first-page":"111619","DOI":"10.1016\/j.ejmech.2019.111619","article-title":"Discovery of novel indolylarylsulfones as potent HIV-1 NNRTIs via structure-guided scaffold morphing","volume":"182","author":"Zhao","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2021.116531_b0105","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1016\/j.bmc.2017.06.022","article-title":"Discovery of novel DAPY-IAS hybrid derivatives as potential HIV-1 inhibitors using molecular hybridization based on crystallographic overlays","volume":"25","author":"Huang","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2021.116531_b0110","doi-asserted-by":"crossref","first-page":"115927","DOI":"10.1016\/j.bmc.2020.115927","article-title":"Novel indolylarylsulfone derivatives as covalent HIV-1 reverse transcriptase inhibitors specifically targeting the drug-resistant mutant Y181C","volume":"30","author":"Gao","year":"2021","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2021.116531_b0115","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.cclet.2020.03.028","article-title":"New techniques and strategies in drug discovery","volume":"31","author":"Du","year":"2020","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.bmc.2021.116531_b0120","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1039\/D0CS01084G","article-title":"Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses","volume":"50","author":"Ma","year":"2021","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.bmc.2021.116531_b0125","doi-asserted-by":"crossref","first-page":"14015","DOI":"10.1021\/jacs.8b07366","article-title":"Sub-picomolar Inhibition of HIV-1 Protease with a Boronic Acid","volume":"140","author":"Windsor","year":"2018","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2021.116531_b0130","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1021\/acs.jmedchem.8b01719","article-title":"Design of N-Benzoxaborole Benzofuran GSK8175-Optimization of Human Pharmacokinetics Inspired by Metabolites of a Failed Clinical HCV Inhibitor","volume":"62","author":"Chong","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116531_b0135","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1016\/j.apsb.2021.01.010","article-title":"Recent developments in the medicinal chemistry of single boron atom-containing compounds","volume":"11","author":"Song","year":"2021","journal-title":"Acta Pharmaceut Sinica B"},{"key":"10.1016\/j.bmc.2021.116531_b0140","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1016\/j.tetlet.2007.07.130","article-title":"A rapid synthesis of 3-sulfenyl indoles using Selectfluor\u2122","volume":"48","author":"Yadav","year":"2007","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.bmc.2021.116531_b0145","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1021\/jm031147e","article-title":"Simple, short peptide derivatives of a sulfonylindolecarboxamide (L-737,126) active in vitro against HIV-1 wild type and variants carrying non-nucleoside reverse transcriptase inhibitor resistance mutations","volume":"47","author":"Silvestri","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116531_b0150","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1021\/jm101614j","article-title":"Indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: new cyclic substituents at indole-2-carboxamide","volume":"54","author":"La Regina","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116531_b0155","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1021\/acs.jmedchem.9b02161","article-title":"Discovery of peptide boronate derivatives as histone deacetylase and proteasome dual inhibitors for overcoming bortezomib resistance of multiple myeloma","volume":"63","author":"Zhou","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116531_b0160","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0166-0934(88)90134-6","article-title":"Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds","volume":"20","author":"Pauwels","year":"1988","journal-title":"J Virol Methods"},{"key":"10.1016\/j.bmc.2021.116531_b0165","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nprot.2007.517","article-title":"Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later","volume":"3","author":"Pannecouque","year":"2008","journal-title":"Nat Protoc"},{"key":"10.1016\/j.bmc.2021.116531_b0170","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1016\/j.bmc.2009.07.004","article-title":"Novel 1,2,3-thiadiazole derivatives as HIV-1 NNRTIs with improved potency: Synthesis and preliminary SAR studies","volume":"17","author":"Zhan","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2021.116531_b0175","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0166-0934(93)90054-U","article-title":"Poly A-linked colorimetric microtiter plate assay for HIV reverse transcriptase","volume":"44","author":"Suzuki","year":"1993","journal-title":"J Virol Methods"},{"key":"10.1016\/j.bmc.2021.116531_b0180","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.bmc.2006.12.003","article-title":"Design, synthesis, and evaluation of 2-aryl-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents","volume":"15","author":"Rawal","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2021.116531_b0185","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1039\/C9OB00032A","article-title":"Targeting the hydrophobic channel of NNIBP: discovery of novel 1,2,3-triazole-derived diarylpyrimidines as novel HIV-1 NNRTIs with high potency against wild-type and K103N mutant virus","volume":"17","author":"Zhou","year":"2019","journal-title":"Org Biomol Chem"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621005393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621005393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:16:34Z","timestamp":1760836594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089621005393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":37,"alternative-id":["S0968089621005393"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116531","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV\u20111 non-nucleoside reverse transcriptase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116531","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116531"}}